Standard & Poor's
http://www2.standardandpoors.comStandard & Poor’s, a division of McGraw-Hill (NYSE: MHP), produces financial research and analysis on stocks and bonds. It provides credit ratings on public and private corporations and is designated as a Nationally Recognized Statistical Rating Organization (NRSRO) by the SEC. The firm’s long-term credit ratings range from “AAA” to “D” and its short-term credit ratings range from “A-1” to “D”. Standard & Poor’s also publishes indexes including the S&P 500.
View Older Stories
-
Buffett's Berkshire 13F Shows Reduced Stake in Goldman Sachs (GS), Liquidated Travelers (TRV), Phillips 66 (PSX) (more...)
-
Buffett's Berkshire Enters Biogen (BIIB), Krogers (KR) (more...) 13F
-
Trade hopes move S&P 500 close to new record high
-
Wolfe Research Starts Teva Pharma (TEVA) at Peerperform
-
JANA Partners Raises ConAgra Foods (CAG) & SPY, Lowers or Liquidates All Else
-
JANA Partners Enters Centene (CNC), Mastercard (MA), Salesforce (CRM); Raises Microsoft (MSFT), Lowers Apple (AAPL) (More...)
-
Jana's 13F Shows New Stakes in Exact Sciences (EXAS), Keurig Dr Pepper (KDP), Exits Facebook (FB) (More...)
-
Jana's 13F Shows New Stake in Facebook (FB), Dr Pepper Snapple (DPS), Wells Fargo (WFC), Increase in Pinnacle (PF) (More...)
-
JANA Shows New Stakes in Apple (AAPL), Boston Scientific (BSX), Dropbox (DBX), iQIYI (IQ) (more..) -13F
-
JANA Partners Enters Facebook (FB), Comcast (CMCSA) , Teva (TEVA) (more...) - 13F
-
Teva Pharma (TEVA) Cut to Junk by S&P; to BB/Stable from BBB-/Watch
-
Teva Pharma (TEVA) May be Cut to Junk at S&P; to BBB-/Watch Neg From BBB-/Negative - Bloomberg
-
Wells Fargo Downgrades Teva Pharma (TEVA) to Underperform
-
Wells Fargo Comments on Teva (TEVA) Debt Downgrade
-
S&P 500 chalks up record high as fear gives way
-
Appaloosa Management's 13F Shows New Stakes in Southwestern Energy (SWN), Chesapeake Energy (CHK), Alibaba (BABA), Increase in Western Digital (WDC), Decrease in GM (GM) (more...)
-
Tepper's Appaloosa 13F Shows New Stake in Bank of America (BAC), Increase in GM (GM), Arcelor Mittal (MT), Southwest Airlines (LUV), (More...)
-
Pre-Open Movers 04/04: (GNCMA) (PRTK) (CYCC) Higher; (AYI) (KATE) (NVDA) Lower (more...)
-
Tepper's Appaloosa Enters American Airlines (AAL), Micron (MU), JC Penney (JCP), Pfizer (PFE) (more...) - 13F
-
Oppenheimer Assumes Teva Pharma (TEVA) at Outperform
-
Oppenheimer Cuts Price Target as Teva Pharma (TEVA) Updates Guidance
-
S&P Downgrades Teva Pharma (TEVA) to 'BBB'; Outlook is Stable (AGN)
-
Higher health stocks and falling oil leave S&P 500 flat
-
Blue Ridge Capital Shows New Stakes in Ambrella (AMBA), CP (CP), Teva (TEVA) (more...)
-
Market Wrap: U.S. Manufacturing Inched Higher in Sept.; Auto SAAR at Decade-High Levels; Tyler Tech Makes Key Purchase
-
Pre-Open Stock Movers 10/01: (XOMA) (SRPT) (PBF) Higher; (MDGN) (CXO) (AGCO) Lower (more...)
-
Teva Pharma (TEVA) Ratings Cut to 'BBB+' by S&P; Remains on CreditWatch Negative
-
Market Wrap: Chinese Stock Pressure Hits U.S. Markets; Durable Orders Outpace in June; Merger Monday
-
Streetinsider.com's Hot Lunchtime Reads 7/27: (TEVA) (OII) (F) (RJET)
-
Notable Mergers and Acquisitions 7/27: (TEVA)/(AGN) (WAB) (BECN) (SNY) (XUE)
-
Pre-Open Stock Movers 07/27: (MAG) (TEVA) (AGN) Higher; (BLPH) (MYL) (GRUB) Lower (more...)
-
Wall Street drops as China stock slump stokes growth fears
-
Market Wrap: Avago, Broadcom Make it Official; Pending Home Sales Ramp in April; JPMorgan Plans Major Job Cuts
-
Teva Pharma (TEVA) Sends Letter to Mylan (MYL); Aims to Address Merger Concerns
-
Market Wrap: Apple Does it Again in Q2; Mylan Rejects Teva Bid; Applied Materials, Tokyo Electron Terminate Merger
-
Mylan (MYL) Rejects Unsolicited Teva (TEVA) Proposal
-
Top 10 News for 4/20 - 4/24: Comcast Cancels Time Warner Deal; Teva/Mylan/Perrigo Saga Continues; Big Names, Solid Earnings
-
Market Wrap: Teva Makes it Official with Mylan; DuPont Warns on FX Impact; Yahoo!'s Display Revenue Struggle Continues
-
Market Wrap: Pending Home Sales Reach Multi-Year Highs; M&A Rules the Day; Tesla Plans New Product Launch
-
Teva Pharma (TEVA) Ratings Affirmed by S&P; Business Risk Profile Revised to 'Strong'
-
Market Wrap: China GDP Growth Slowed 2014; Netflix Int'l Growth Continues; Starboard Pushes for Staples Deal
-
Guggenheim Names Top 2015 Picks in Specialty Pharmaceuticals; Sees Continued M&A (VRX) (ZTS) (NEOT)
-
Market Wrap: Retail Sales Robust in Nov.; Staples, Office Depot Deal in the Works?; Two Notable IPOs Launch
-
Rosenstein's JANA Partners 13F Confirms Apache (APA), Exits GM (GM), Enters FMC Corp (FMC) and Motorola Solutions (MSI) (more...)
-
Rosenstein's JANA Partners Takes New Applied Materials (AMAT), eBay (EBAY) Stakes; Raises AIG (AIG), Liquidates Mondelez (MDLZ) (more...)
-
Market Wrap: Leaders Out at Dow Jones, PIMCO; New Activist in Dow Chemical; Big Names, Big Earnings
-
Market Wrap: Most Fed Officials Supported Tapering; JCPenney's Fuzzy Update; A Bid for Riverbed
-
Market Wrap: CPI Flattens in Nov.; Microsoft Undecided on CEO...for Now; Homebuilders Gain Confidence
-
Market Wrap: Dow Closes Below 15K; Gigamon Goes Public; 10-Year Pfizer Fight Ends
-
Canaccord Genuity on Pharmaceuticals: Generic Valuation at Historical Trough Level Ahead of Meetings